stockrow
Monday 9 November 2026
Export PDSB’s income statement to Excel — free account
PDS Biotechnology Corporation
PDSB- EPS
- +14.3%
- Free cash flow
- +69.3%
- Total debt
- −66.6%
Quarter to June 2026, against a year earlier
1.23
0.06
+5.13%
Follow PDSB
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (543.97%) | (254.09%) | (244.16%) | (221.81%) |
+8 more TTM periods Free account |
|
| (136.65%) | (93.05%) | (90.95%) | (80.05%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
653.10% | (259.50%) | (182.60%) | (237.49%) | |
Free Cash Flow per Share |
(0.30) | (0.42) | (0.60) | (0.69) | |
Free Cash Flow |
(16.78) | (23.09) | (27.75) | (32.28) | |
| Other line items | |||||
Cash ROIC |
(264.35%) | (63.83%) | (52.51%) | (67.86%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(4.18) | (5.34) | (5.91) | (6.06) | |
Operating CF/Net income |
0.50 | 0.69 | 0.80 | 0.93 | |
Depreciation/Fixed assets |
5.33 | 15.61 | 13.43 | 11.45 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.30) | (0.42) | (0.60) | (0.69) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates